Abbott Laboratories
XHAM:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
XHAM:ABL
|
US |
|
I
|
Imperial Brands PLC
OTC:IMBBY
|
UK |
|
G
|
Global Payments Inc
F:GLO
|
US |
|
C
|
Cigna Corp
F:CGN
|
US |
|
Birkenstock Holding PLC
F:7PV
|
UK |
|
M
|
Mitsubishi Corp
F:MBI
|
JP |
|
C
|
CF Industries Holdings Inc
XMUN:C4F
|
US |
|
S
|
Stellantis NV
XHAM:8TI
|
NL |
|
Japfa Comfeed Indonesia Tbk PT
IDX:JPFA
|
ID |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 104.6 EUR with a low forecast of 80.48 EUR and a high forecast of 123.69 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
104.6
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 104.6 EUR with a low forecast of 80.48 EUR and a high forecast of 123.69 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 20%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 22%.
